Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

NCT05538195 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Molecular Study and Precision Medicine for Colorectal Cancer

NCT05883683 ·Status: NOT_YET_RECRUITING

Efficacy Study of TKcell in Advanced Colorectal Cancer

NCT00854971 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer

NCT06047015 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

NCT02843607 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer

NCT02849379 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

RC48-ADC Combined With Bevacizumab in HER2-positive Advanced Colorectal Cancer

NCT05785325 ·Status: UNKNOWN ·Phase: PHASE2

Fluorescent Lymphography-Guided Lymphadenectomy In Laparoscopic Proctectomy

NCT03854890 ·Status: UNKNOWN ·Phase: NA

Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer

NCT06946615 ·Status: RECRUITING ·Phase: PHASE1

Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma

NCT05461235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

NCT02849314 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer

NCT04326296 ·Status: UNKNOWN ·Phase: PHASE1

Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer

NCT02343835 ·Status: COMPLETED ·Phase: NA

An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)

NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer

NCT05092750 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial

NCT05755685 ·Status: UNKNOWN ·Phase: PHASE2

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

NCT02482454 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

NCT02419677 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

NCT04499586 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer

NCT06485609 ·Status: RECRUITING ·Phase: NA

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

NCT03524274 ·Status: WITHDRAWN ·Phase: PHASE2

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

NCT06751966 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.

NCT07343791 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer

NCT01012804 ·Status: WITHDRAWN

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

NCT05213195 ·Status: RECRUITING ·Phase: PHASE1